BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15181741)

  • 1. [Does beta-2 microglobulin measurement play role in diagnostics of childhood malignancies?].
    Bień E; Balcerska A; Ciesielski D
    Wiad Lek; 2004; 57(1-2):8-11. PubMed ID: 15181741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
    Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
    Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].
    Bień E; Balcerska A
    Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias.
    Bien E; Balcerska A; Adamkiewicz-Drozynska E; Rapala M; Krawczyk M; Stepinski J
    Clin Biochem; 2009 Jul; 42(10-11):1144-57. PubMed ID: 19376105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic and prognostic significance of serum soluble interleukin 2 receptor in children with malignancies].
    Bień E; Balcerska A; Ciesielski D
    Wiad Lek; 2006; 59(1-2):10-5. PubMed ID: 16646285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
    Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
    Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadal function in boys with newly diagnosed cancer before the start of treatment.
    Wigny KM; van Dorp W; van der Kooi AL; de Rijke YB; de Vries AC; Smit M; Pluijm SM; van den Akker EL; Pieters R; Laven JS; van den Heuvel-Eibrink MM
    Hum Reprod; 2016 Nov; 31(11):2613-2618. PubMed ID: 27680030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
    Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
    Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum selenium levels in untreated children with acute lymphoblastic leukemia. I.
    Mikac-Dević M; Ferenec D; Tiefenbach A
    J Trace Elem Electrolytes Health Dis; 1990 Mar; 4(1):7-10. PubMed ID: 2135960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
    Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
    Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta 2 microglobulin in serum--a "tumor marker" in malignant lymphomas?].
    Aulbert E; Steffens O
    Med Klin (Munich); 1990 Jan; 85(1):13-7. PubMed ID: 2179698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The experience of a single Australian paediatric oncology unit. 1000 patients 1964-1987.
    McCowage GB; Vowels MR; Brown R; O'Gorman-Hughes D; White L; Marshall G
    Med J Aust; 1993 Oct; 159(7):453-5, 458. PubMed ID: 8412916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue polypeptide-specific antigen (TPS) in pediatric malignancies.
    Rebhandl W; Paya K; Felberbauer FX; Fuchs R; Henkel J; Bieglmayer C; Horcher E
    Anticancer Res; 1997; 17(4B):2865-8. PubMed ID: 9329549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
    Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voûte PA; Morris-Jones P; Greenberg M
    Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of ABO blood groups in acute leukaemias and lymphomas.
    Vadivelu MK; Damodaran S; Solomon J; Rajaseharan A
    Ann Hematol; 2004 Sep; 83(9):584-7. PubMed ID: 15175895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
    Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
    Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group.
    Kowalczyk J; Nurzyńska-Flak J; Armata J; Bogusławska-Jaworska J; Rokicka-Milewska R; Sońta-Jakimczyk D; Balwierz W; Chybicka A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Pawelec K
    Med Sci Monit; 2004 Mar; 10(3):CR117-22. PubMed ID: 14976453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The importance of the radioimmunological determination of tumor markers in the diagnosis of malignant lymphomas].
    Purizhanskiĭ II; Pavlichuk SN; Toritsina LK
    Med Radiol (Mosk); 1989 Nov; 34(11):48-51. PubMed ID: 2685505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.